Twist Bioscience CORP Form 4 insider transactions

Twist Bioscience's SVP of Human Resources, Paula Green, sold 598 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience's Chief Financial Officer, Adam Laponis, sold 887 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Twist Bioscience CEO Emily M. Leproust sold 2,663 shares of common stock to cover tax withholding obligations related to Restricted Stock Unit vesting.

Twist Bioscience Corp. has granted its Senior Vice President, Chief Legal Officer & Corporate Secretary, Dennis Cho, 25,465 restricted stock units.

Twist Bioscience Corp's SVP of Human Resources, Paula Green, was granted 26,200 restricted stock units, vesting quarterly over four years.

Twist Bioscience Director Jan Johannessen reported the sale of 7,044 shares of common stock at $24.77 per share.

Twist Bioscience CEO Emily M. Leproust received an award of 146,914 restricted stock units, vesting over 48 months.

Patrick John Finn, President and COO of Twist Bioscience Corp, received a restricted stock unit award of 68,740 shares.

Twist Bioscience's Chief Financial Officer, Adam Laponis, was granted 32,648 restricted stock units, vesting quarterly over four years.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, was granted 16,324 restricted stock units, increasing his beneficial ownership to 67,194 shares.

Twist Bioscience's Chief Legal Officer, Dennis Cho, sold 1,019 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Twist Bioscience's President and COO, Patrick John Finn, sold 2,755 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 1,084 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience CEO Emily M. Leproust sold 4,887 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 160 shares of common stock to cover tax withholding obligations related to RSU vesting.

Twist Bioscience's Chief Legal Officer, Dennis Cho, sold 6,515 shares of common stock to cover tax withholding obligations related to vested performance stock units.

Twist Bioscience's President and COO, Patrick John Finn, sold 17,606 shares of common stock to cover tax withholding obligations related to PSU vesting.

Twist Bioscience's SVP of Human Resources, Paula Green, sold 6,920 shares of common stock to cover tax withholding obligations related to vested Performance Stock Units.

Twist Bioscience CEO Emily M. Leproust sold 31,379 shares of common stock to cover tax withholding obligations related to vested performance stock units.

Twist Bioscience's CFO, Adam Laponis, sold 5,517 shares of common stock to cover tax withholding obligations related to PSU vesting.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 1,016 shares of common stock to cover tax withholding obligations related to vested performance stock units.

Twist Bioscience's Chief Accounting Officer, Robert F. Werner, was awarded 5,633 shares of common stock through performance stock units.

Twist Bioscience Corp's Chief Financial Officer, Adam Laponis, was granted 25,000 shares of common stock through Performance Stock Units after meeting target criteria.

Twist Bioscience's President and COO, Patrick John Finn, reported the acquisition of 79,785 shares of common stock from performance stock units.

Twist Bioscience's Senior Vice President, Chief Legal Officer & Corporate Secretary, Dennis Cho, acquired 29,518 Performance Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience Corp, was awarded 35,513 shares of common stock after performance criteria were met.

Twist Bioscience CEO Emily Leproust acquired 168,976 shares of common stock through the vesting of performance stock units.

Patrick John Finn, President and COO of Twist Bioscience, sold 2,240 shares of common stock at $30.875 per share to satisfy tax withholding obligations from restricted stock unit vesting.

Twist Bioscience CFO Adam Laponis sold shares, including a portion for tax obligations, as disclosed in a recent Form 4 filing.

Twist Bioscience CFO Adam Laponis sold 5,875 shares of common stock to cover tax withholding obligations related to PSU vesting.